The North America Wearable Healthcare Devices Market has exhibited robust growth, fueled by advancements in health monitoring technologies, rising health awareness, and integration of AI-driven analytics. Valued at USD 11,450 million in 2025, it is projected to reach USD 41,250 million by 2035, growing at a CAGR of 13.9% between 2024 and 2035.
The economic impact of tariffs on "North America Wearable Healthcare Devices Market".
Market Growth Drivers
Increasing Prevalence of Chronic Diseases: The rising incidence of chronic conditions like diabetes, cardiovascular disorders, and obesity across North America is driving the adoption of wearable healthcare devices. These devices, such as Fitbit and Apple Watch, allow continuous health monitoring, enabling early intervention and disease management. Companies like Dexcom and Abbott have launched advanced continuous glucose monitoring systems, significantly improving patient outcomes and reducing healthcare costs by enabling proactive management.
Integration of AI and Connectivity: Leading companies such as Apple and Garmin have incorporated artificial intelligence and IoT connectivity in their wearable devices, offering personalized health insights and predictive analytics. This integration enables real-time health data sharing with healthcare providers, facilitating timely interventions and improving user engagement. The ability to sync wearable data with digital health records supports telemedicine growth and enhances remote patient monitoring.
Market Trends
Shift Towards Preventive Healthcare: There’s a notable trend towards leveraging wearables for preventive healthcare in North America. Major brands like Fitbit and Oura are offering devices capable of tracking vital metrics such as heart rate variability, oxygen saturation, and sleep quality. Insurance providers and employers are increasingly partnering with wearable technology companies to incentivize healthier lifestyles through wellness programs, driving market demand.
Hybrid Medical-Consumer Products: Companies like Withings and Samsung are blurring the line between consumer and medical-grade wearables. Devices are now equipped with FDA-approved ECG monitors, arrhythmia detection, and in-depth health analytics alongside traditional activity tracking. This trend reflects consumer expectations for multipurpose wearables that serve both everyday fitness tracking and clinical-grade monitoring.
Market Opportunities
Expansion in Remote Patient Monitoring: The shift towards telehealth creates immense growth opportunities for wearable healthcare device manufacturers. Companies like BioTelemetry are developing advanced solutions that allow remote monitoring and management of patients, especially the elderly and chronically ill, thereby reducing hospital readmissions.
Integration with Healthcare Infrastructure: There’s significant potential for integrating wearable devices into electronic health records and hospital systems. Companies like Philips are partnering with healthcare providers to enable seamless data exchange and automated health insights, further bridging the gap between consumer technology and clinical care.
North America Wearable Healthcare Devices Market Revenue (USD Million), 2020-2035
The market demonstrated consistent growth between 2020 and 2025, with revenues increasing from USD 4,800 million in 2020 to USD 11,450 million in 2025. This upward trajectory is expected to continue, fueled by increasing consumer adoption, technological innovation, and expanding healthcare applications. By 2030, revenues are forecasted to surpass USD 23,000 million, reaching USD 41,250 million by 2035, reflecting a dynamic CAGR of 13.9%. This robust growth highlights the region’s increasing reliance on wearable devices for chronic disease management, fitness monitoring, and preventive healthcare.
North America Wearable Healthcare Devices Market by Regions Share (%), 2025
In 2025, the United States dominates the North American wearable healthcare devices market with a 78% share, driven by robust healthcare infrastructure and high technology adoption rates. Canada holds 15%, benefiting from increasing government digital health initiatives and rising health awareness. Mexico accounts for about 4% amid growing market entry by global players and rising health concerns. Other regions, including the Caribbean and Central American territories, collectively make up 3% of the market. The pie chart illustrates the strong concentration in the US market with gradual growth in Canada and Mexico.
Recent Developments in North America Wearable Healthcare Devices Market (Last 6 Months)
Apple announced the launch of its enhanced Apple Watch Series 9 in March 2024, featuring a new AI-powered atrial fibrillation detection algorithm and advanced wearable sensors capable of monitoring respiratory rate and skin temperature with clinical-grade accuracy. This aligns with Apple's continuous push towards making its devices more relevant in preventive healthcare and clinical settings.
Fitbit, a subsidiary of Google, collaborated with Blue Cross Blue Shield in April 2024 for a large-scale health incentivization program across several US states. The program integrates Fitbit wearable data directly into health insurer platforms, offering policyholders personalized wellness coaching, premium discounts, and chronic condition alerts, increasing both consumer engagement and clinical outreach.
Dexcom introduced its G8 continuous glucose monitoring system in May 2024, expanding its market presence in North America. The G8 system offers real-time, minimally invasive glucose tracking with direct smartphone integration and FDA-cleared sharing features. Dexcom’s move strengthens its position amid rising demand for non-invasive, real-time monitoring solutions for diabetic and pre-diabetic populations.
Press Releases